P. Koutsiouba

Squamous Cell Carcinoma Antigen, Tumor-Associated Trypsin Inhibitor, and Carcinoembryonic Antigen for Monitoring Cervical Cancer

Dimitrios Pectasides, Nicholas G. Economides, J. Bourazanis et al. · American Journal of Clinical Oncology · 1994 · 26 citations

Medicine, Oncology, Pathology +17

Immunoscintigraphy with131I-labelled HMFG2 and HMFG2 F(ab')2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients

A. Athanassiou, Dimitrios Pectasides, K. Pateniotis et al. · International Journal of Cancer · 1988 · 20 citations

Medicine, Nuclear Medicine, Radiology +15

Immunoscintigraphy with131I-labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patients

Dimitrios Pectasides, K. Pateniotis, L Tzimis et al. · International Journal of Cancer · 1988 · 15 citations

Medicine, Oncology, Surgery +15

Is there a role of whole body bone scan in early stages of non small cell lung cancer patients.

Lydia Iordanidou, Erasmia Trivizaki, Sofia Saranti et al. · PubMed · 2007 · 13 citations

Medicine, Oncology, Radiology +17

Squamous Cell Carcinoma Antigen (SCC), Carcinoembryonic Antigen (CEA), and Tumour-Associated Trypsin Inhibitor (TATI) for Monitoring Head and Neck Cancer

Dimitrios Pectasides, J. Bourazanis, Nicholas G. Economides et al. · The International Journal of Biological Markers · 1993 · 11 citations

Medicine, Oncology, Cancer Immunology +11